SCHEMBL29565801

SCHEMBL29565801

CNCc1ccc(-c2cc(-c3cncc(-c4ccc(S(=O)(=O)C(C)C)cc4)n3)on2)cc1

nearest known ligand 0.72

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ATR Q13535 20/20 0.72
▸ ATM Q13315 11/20 0.72
▸ PRKDC P78527 6/20 0.72
▸ GSK3B P49841 3/20 0.72
▸ JAK2 O60674 1/20 0.72
▸ ABL1 P00519 1/20 0.72
▸ KIT P10721 1/20 0.72
▸ SERPINA2 P20848 1/20 0.72
▸ PIK3R1 P27986 1/20 0.72
▸ FLT4 P35916 1/20 0.72
▸ FLT3 P36888 1/20 0.72
▸ PIK3CA P42336 1/20 0.72
▸ MTOR P42345 1/20 0.72
▸ SYK P43405 1/20 0.72
▸ GSK3A P49840 1/20 0.72
▸ MAP3K9 P80192 1/20 0.72
▸ KCNH2 Q12809 1/20 0.72
▸ MERTK Q12866 1/20 0.72
▸ DYRK2 Q92630 1/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3699040 1.00 ATR (0.72) ATRATMPRKDCGSK3BJAK2
SCHEMBL17826097 0.91 ATR (0.60) ATRATMPRKDCGSK3BJAK2
SCHEMBL17826096 0.90 ATR (0.73) ATRATMPRKDCGSK3BJAK2
SCHEMBL16420441 0.90 ATR (0.62) ATRATMPRKDCGSK3BJAK2
SCHEMBL16420452 0.89 ATR (0.75) ATRATMPRKDCGSK3BJAK2
SCHEMBL16420477 0.89 ATR (0.63) ATRATMPRKDCGSK3BJAK2
SCHEMBL17826098 0.88 ATR (0.63) ATRATMPRKDCGSK3BJAK2
SCHEMBL16420488 0.88 ATR (0.60) ATRATMPRKDCGSK3BJAK2
SCHEMBL16420486 0.88 ATR (0.72) ATRATMPRKDCGSK3BJAK2
SCHEMBL18177382 0.88 ATR (0.59) ATRATMPRKDCGSK3BJAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022090063-A1 ATR INHIBITORS FOR USE IN THE TREATMENT OF VIRAL INFECTIONS MERCK PATENT GMBH (DE) 2022-05-05 — — WO disclosed
Send feedback